SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-146070
Filing Date
2016-09-22
Accepted
2016-09-22 12:28:49
Documents
6
Period of Report
2016-09-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-18840_18k.htm 8-K 54565
2 EX-10.1 a16-18840_1ex10d1.htm EX-10.1 421825
3 EX-10.2 a16-18840_1ex10d2.htm EX-10.2 147300
4 EX-10.3 a16-18840_1ex10d3.htm EX-10.3 161246
5 EX-99.1 a16-18840_1ex99d1.htm EX-99.1 11754
6 GRAPHIC g188401mmi001.jpg GRAPHIC 2724
  Complete submission text file 0001104659-16-146070.txt   801953
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 161897189
SIC: 3841 Surgical & Medical Instruments & Apparatus